Prot# GL 303: Randomized Study of Fludarabine and Cyclophosphamide With or Without Genasense? (Bcl-2 Antisense Oligonucleotide) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia

Project: Research project

Project Details

StatusFinished
Effective start/end date9/24/01 → 8/22/07

Funding

  • Inveresk Research, Inc. (GL 303)
  • Genta Incorporated (GL 303)